C. Toscano

OP0319 DIAGNOSTIC ACCURACY OF ULTRASOUND IN CALCIUM PYROPHOSPHATE DEPOSITION DISEASE: PRELIMINARY RESULTS OF THE OMERACT US IN CPPD SUB-GROUP

A. Iagnocco, G. Herrero-Beaumont, E. Naredo, 2019, Oral Presentations.

One year in review 2016: idiopathic inflammatory myopathies.

C. Baldini, E. Cioffi, S. Tenti, 2016, Clinical and experimental rheumatology.

Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study

A. Iagnocco, G. Herrero-Beaumont, E. Naredo, 2020, Annals of the Rheumatic Diseases.

Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints—an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force

A. Iagnocco, E. Naredo, G. Filippou, 2018, Annals of the rheumatic diseases.

Definition and Reliability Assessment of Elementary Ultrasonographic Findings in Calcium Pyrophosphate Deposition Disease: A Study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force

A. Iagnocco, E. Naredo, G. Filippou, 2017, The Journal of Rheumatology.

Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study

A. Migliore, B. Frediani, L. Cantarini, 2020, Drugs in R&D.

Histology of the synovial membrane of patients affected by osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease vs. osteoarthritis alone: a pilot study

G. Filippou, B. Frediani, S. Carta, 2016, Scandinavian journal of rheumatology.